Timing of FFR-guided PCI for Non-IRA in NSTEMI and MVD (OPTION-NSTEMI)
Recruiting
N/A
Interventional Study
Myocardial Infarction, Acute
Multi-Vessel Coronary Artery Stenosis
Multi Vessel Coronary Artery Disease
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 19 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 1,014 (estimated)
- Sponsor
- Chonnam National University Hospital · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Many patients with non-ST-segment elevation myocardial infarction (NSTEMI) have multivessel coronary artery disease (MVD), which is associated with poor clinical outcomes. However, there have been few studies regarding revascularization strategy in patients with NSTEMI and MVD. Therefore, we planned to perform prospective, open-label, randomized trial to evaluate the efficacy and safety of immedia…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
1. Age ≥ 19 years old
2. Non-ST-segment elevation myocardial infarction
* Angina pectoris or equivalent ischemic chest discomfort with at least 1 of 3 features and,
* occurs at rest, usually lasting \> 10 minutes
* severe and new onset (within the prior 4-6 weeks)…
Contacts